纵横研报
Ticker Detail

603811.SHG

¥7.81+5.40% 诚意药业 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
Zhejiang Cheng Yi Pharmaceutical Co Ltd
医疗健康 · 专科与仿制药

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. engages in the research, development, production, and sales of formulations and active pharmaceutical ingredients in China and internationally. The company offers glucosamine hydrochloride raw materials and preparations, gastrodin raw materials, ribavirin preparations raw materials, and sulfur dioxide raw materials. It also provides injections, food, capsules, tablets, traditional Chinese medicines, preparations, and intermediates; and joint-related drugs, diuretics and antihypertensive drugs, antiviral drugs, antitumor drugs, vitamins, and sedative and brain-boosting drugs, as well as other health products and medical instruments. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is based in Shanghai, China.

MARKET 市值 3.35B CNY PE 16.6x 52W ¥7.1 – ¥16.97 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY 8.3% ROE 14.1% 营业利润率 22.1% 净利润率 23.4%
ANALYST 股息率 2.96%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制